Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 21 to 50

Comparing atenolol and metoprolol for reducing bleeding during nasal surgeries

Official title: Premedication With Atenolol Versus Metoprolol for Controlled Hypotensive Anesthesia During Nasal Surgeries. A Randomized Clinical Trial

Run by Damanhour Teaching Hospital · NCT04914234 · Data updated 2026-11-12

This study is testing whether atenolol or metoprolol works better to reduce bleeding during nasal surgeries for patients needing general anesthesia.

More Hypotension Drug-Induced trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages21 Years to 50 Years
SexAll
Enrollment60 (estimated)
SponsorDamanhour Teaching Hospital
Government
Locations1 site (Damanhūr, El-Beheira)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedJanuary 15, 2027
Study endsJanuary 30, 2027
Registry record updatedSeptember 21, 2026
Trial IDNCT04914234 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 21 to 50 years with an ASA physical status of II or lower who are scheduled for nasal surgeries.

Probably not a fit

Patients with significant comorbidities, such as heart disease, chronic respiratory conditions, or those on anticoagulants, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the safety and efficacy of oral atenolol versus oral metoprolol as premedication for controlled hypotensive anesthesia in patients undergoing nasal surgeries. The study involves a prospective, randomized, double-blind design with 60 participants who are candidates for general anesthesia. Patients will be divided into two groups, with one receiving atenolol and the other metoprolol, to assess which medication better controls intraoperative bleeding and improves surgical outcomes.

Why it matters

Potential benefit: If successful, this study could lead to improved surgical outcomes and reduced complications during nasal surgeries by effectively managing intraoperative bleeding.

How similar studies have gone: Previous studies have explored the use of beta-blockers for controlled hypotension, indicating potential for success, but this specific comparison of atenolol and metoprolol is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* American Society of Anesthesiologists (ASA) physical status ≤ II
* Age from 21 to 50 years

Exclusion Criteria:

* ASA physical status \> II
* Age \< 21 years or \> 50 years
* Pregnant women
* Breastfeeding
* Bronchial asthma
* Chronic obstructive pulmonary disease
* Diabetes Mellitus
* Hypertension
* Ischemic heart disease
* Rheumatic heart disease
* Heart failure
* Heart block
* Sick sinus syndrome
* Sinus bradycardia
* Chronic hypotension
* Anemia (Hb \< 10 g/dl)
* Renal or hepatic dysfunction
* Central nervous system disease
* Allergic fungal sinusitis
* Patients on beta-blockers
* Alcohol or drug abuse
* Anticoagulation therapy,
* Bleeding diathesis
* Agents influencing autonomic nervous system
* Allergy to the study drugs
* Any contraindication of oral intake

Where it's running

  • Damanhour Teaching Hospital
    Damanhūr, El-Beheira, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.